Quantified

APRIL 13, 2023

In 2023, sales training simulations address a new concern that sales managers are just beginning to face return anxiety. As employees return to work after extended periods of remote work or reenter the workforce after COVID-related interruptions, companies find they can resolve return anxiety through experiential learning. Sales training simulations fit the bill: they provide experience, let salespeople of all skill levels practice new-to-them skills, and foster an experiential learning environm

Training 52

Training Sales Prospecting Sales Management 52

PharmaVoice

APRIL 13, 2023

The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.

Pharma 59

Pharma 59

Fierce Pharma

APRIL 10, 2023

New WHO recommendations on COVID vaccines create more revenue uncertainty: analyst kdunleavy Mon, 04/10/2023 - 10:47

265

265

European Pharmaceutical Review

APRIL 13, 2023

Psychedelics are a class of psychoactive substances that produce temporary changes in perception, mood and cognitive processes. 1 Some psychedelics are found in nature, including psilocybin, a naturally occurring molecule found in almost 150 species of mushrooms which turns into psilocin once ingested, causing psychedelic effects. Other psychedelics are man-made, such as lysergic diethylamide (LSD), which was first synthesised in 1938 by Albert Hofmann at a laboratory in Switzerland. 2 LSD is wi

Medicine 131

Medicine Food and Drug Administration Doctors Medical 131

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

MedCity News

APRIL 13, 2023

Virtual reality and podcasts are two innovative tools that can help captivate your audience and differentiate your healthcare brand. By utilizing these cutting-edge technologies, you can stay ahead of the competition and create more engaging marketing campaigns.

Healthcare 114

Healthcare Healthcare Marketing Competition 114

Pharmaceutical Technology

APRIL 14, 2023

Ghana’s Food and Drug Authority (FDA) has approved R21/Matrix-M malaria vaccine in children aged 5 to 36 months, marking the first regulatory clearance for the University of Oxford-developed vaccine in any country in the world. Serum Institute of India (SIIPL), manufacturer and licence holder of the vaccine, has been notified of the registration by Ghana’s FDA.

Manufacturing 111

Manufacturing FDA Food Safety 111

European Pharmaceutical Review

APRIL 10, 2023

The high reliability of matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) systems for microbiological identification offer an alternative to serological-based methods, according to a review by researchers. “New technologies for the accurate and rapid identification of bacteria are essential in various fields of applied microbiology.

Media 127

Media Healthcare Healthcare Pharmaceutical 127

MedCity News

APRIL 14, 2023

A panel discussion at the annual Abarca Forward conference in Puerto Rico last month sought to identify some of the innovative financial approaches that can be applied to managing the high price of novel therapies. Conversations also addressed what payers need for these financing models to be sustainable.

Management 115

Management Biopharma Pharma 115

Pharmaceutical Technology

APRIL 13, 2023

Dyadic International has announced expansion of a licence agreement for its C1-cell protein expression platform with South African consortium Rubic One Health. The expanded licence will include the development of vaccines and therapeutic proteins beyond Covid-19 for human and animal health markets in Africa. During the Covid-19 pandemic, vaccination rates of many countries in Africa were significantly trailing the rest of the world.

Distribution 111

Distribution Manufacturing Media Marketing 111

Fierce Pharma

APRIL 13, 2023

Sickle cell disease gene therapies from Vertex, bluebird can be cost-effective at $1.

297

297

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

APRIL 14, 2023

The current progress, challenges and opportunities for achieving stable formulations of nucleic acid (NA) therapeutics with novel drug delivery systems (DDSs) has been discussed in a paper published in Pharmaceutics. Over the past decade, the impact of nucleic acid (NA)-based biopharmaceuticals has been facilitated by breakthroughs associated with high-end manufacturing and pharmaceutical drug delivery.

Manufacturing 105

Manufacturing Pharmaceutical 105

MedCity News

APRIL 14, 2023

Ada Health recently announced that Jefferson Health is deploying its technology across its entire enterprise as part of a digital front door initiative. The Berlin-based company’s AI-powered symptom assessment and care navigation tools helps health systems achieve a robust digital front door, which means staff members don’t have to spend as much time triaging patients or helping them navigate the process of finding care.

Patients 112

Patients 112

Pharmaceutical Technology

APRIL 14, 2023

Clinical-stage biopharmaceutical company TORL BioTherapeutics has raised $158m in a Series B financing round for advancing the development of new biologics for cancer treatment. TORL BioTherapeutics is a newly formed, US-based company focused on the development of novel antibody-based therapeutics for cancer patients. Led by Goldman Sachs Asset Management, the financing round has also seen participation from Deep Track Capital, Moore Strategic Ventures, Cowen Healthcare Investments, Bristol Myer

Management 105

Management Leads Patients Healthcare 105

Fierce Pharma

APRIL 14, 2023

Ghana approves University of Oxford's malaria vaccine ahead of key WHO review zbecker Fri, 04/14/2023 - 11:13

259

259

Advertisement

European Pharmaceutical Review

APRIL 12, 2023

Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV): Amyloid beta program (ATV:Aβ). [the aim of the collaboration is] to advance the next generation of Aβ immunotherapies for the treatment of Alzheimer’s disease” “This decision is an important next step of our collaboration with Denali… that aims to advance the next generation of Aβ immunotherapies for the treatment of Alzheimer’s disease,” stated Dominic Walsh, Head of the Neurodegenerative Research Unit a

Transportation 102

Transportation Engineering Safety Sales 102

MedCity News

APRIL 14, 2023

The American Health Care Association and the National Center for Assisted Living reported in June that nearly half of the nation’s 14,000 nursing homes are facing severe labor shortages, and 73 percent of those facilities are concerned about closing.

112

112

Pharmaceutical Technology

APRIL 11, 2023

The US government is reportedly investing more than $5bn in a programme to accelerate the development of new Covid-19 vaccines and treatments. Dubbed Project Next Gen, the new effort will follow an approach similar to that of Operation Warp Speed, which developed and delivered vaccines to Covid-19 patients in 2020 by forming private-public partnerships for the rapid development of new vaccines.

Government 105

Government Marketing Patients 105

Fierce Pharma

APRIL 14, 2023

AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin aliu Fri, 04/14/2023 - 22:19

Patients 233

Patients 233

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

European Pharmaceutical Review

APRIL 14, 2023

Oligonucleotide therapeutics represent a relatively novel class of drug, with the potential to modulate drug targets that were previously considered intractable, and with the benefit of fast clinical development times. 1 At the WuXi TIDES Forum in March, experts vocalised their opinions on the current trends and challenges they have faced in developing these innovative treatments.

Manufacturing 98

Manufacturing Consulting Pharmaceutical Marketing 98

MedCity News

APRIL 13, 2023

Hospital M&A activity remained strong during the first quarter of 2023, according to a new report from Kaufman Hall. Hospitals and health systems announced 15 M&A transactions in the first quarter of 2023, which almost matches the 17 transactions announced in the fourth quarter of 2022.

Healthcare 110

Healthcare Healthcare 110

Pharmaceutical Technology

APRIL 14, 2023

Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. WARF is the patenting and licensing organisation for the University of Wisconsin–Madison in the US. Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation.

Engineering 105

Engineering Patients Leads Pharmaceutical 105

Fierce Pharma

APRIL 14, 2023

FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation zbecker Fri, 04/14/2023 - 18:14

FDA 253

FDA 253

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

APRIL 13, 2023

INTERPHEX 2023 is right around the corner, taking place April 25-27 at the Javits Center in NYC. INTERPHEX is set to bring leading brands and professionals together once again with new features, a reimagined Show Floor and returning Show Floor favourites. From development to distribution, INTERPHEX is the leading global event that takes you through all stages of the pharmaceutical product development lifecycle.

Education 98

Education Pharmaceutical products Pharma Training 98

MedCity News

APRIL 11, 2023

VintaBio manufactures AAV and lentiviral vectors for entities pursuing clinical development of cell and gene therapies. The contract development manufacturing organization’s launch comes as demand for viral vectors continues to outpace the supply of these crucial components of the therapies.

Manufacturing 106

Manufacturing Biopharma Pharma 106

Pharmaceutical Technology

APRIL 10, 2023

The Malaysian Ministry of Health (MoH) has reportedly approved additional indication of Astrazeneca ’s Evusheld 100mg/ml solution for injection (Tixagevimab 100mg/ml and Cilgavimab 100mg/ml) for Covid-19 prevention. Health director-general Tan Sri Dr Noor Hisham Abdullah stated that the approval of Evusheld was granted at the 383rd Drug Control Authority (DCA) meeting.

Medicine 105

Medicine Patients Marketing 105

Fierce Pharma

APRIL 12, 2023

Moderna nabs a win in Arbutus patent case as appeals court upholds prior invalidation zbecker Wed, 04/12/2023 - 11:16

251

251

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

Salesforce

APRIL 12, 2023

Pediatric care is perhaps one of the most sensitive areas of healthcare. Unlike with adult care, clinicians often communicate and receive information second hand from a patient’s parent or guardian. This unique situation means healthcare organizations must ensure that the information they share in regards to a patient’s condition is only distributed to approved parties so pediatric patients can receive the best, most ethical care possible.

Healthcare 98

Healthcare Healthcare Distribution Patients 98

MedCity News

APRIL 10, 2023

The Health Sector Cybersecurity Coordination Center (HC3) recently issued a report letting healthcare organizations know that they are still being heavily targeted by KillNet, a Russian group of cybercriminals. The number of daily attacks KillNet waged against healthcare organizations using Microsoft Azure increased significantly between November 18 and February 17 — from 10-20 attacks per day in November to 40-60 attacks per day in February.

Healthcare 105

Healthcare Healthcare 105

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. Aviceda’s HALOS (high-affinity ligands of sigelcs) nanotechnology platform leverages glycobiology to modulate the innate immune system to develop advanced breakthrough therapeutics, focusing on immuno-oncology.

Medicine 103

Medicine Medical 103

Fierce Pharma

APRIL 12, 2023

AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate aliu Wed, 04/12/2023 - 15:37

220

220

Advertisement

Distribution